Myomo To Participate in Two March Investor Conferences

Rhea-AI Summary

Myomo, Inc. (NYSE American: MYO), a company specializing in wearable medical robotics, is set to participate in two investor conferences in March 2022. The first event is the 34th Annual ROTH Conference from March 13-15 at The Ritz-Carlton, Laguna Niguel, CA, with a Fireside Chat on March 14 at 2:00 p.m. PT. The second is the Oppenheimer’s 32nd Annual Healthcare Conference on March 15-16, featuring a presentation on March 16 at 2:00 p.m. ET. Myomo’s product line, MyoPro, assists those with upper-limb paralysis to regain functionality.

BOSTON--(BUSINESS WIRE)-- Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announces that management will participate in two investor conferences during March:

• 34^th Annual ROTH Conference, March 13-15, 2022 at The Ritz-Carlton, Laguna Niguel, CA. Management will participate in a “Fireside Chat” on Monday, March 14^th at 2:00 p.m. PT and will be available for one-on-one meetings throughout the conference.
• Oppenheimer’s 32^nd Annual Healthcare Conference, March 15-16, 2022. Management will deliver a company presentation on Wednesday, March 16^th at 2:00 p.m. ET and will be available for one-on-one virtual meetings. A live webcast of the presentation will be available here and will also be archived in the Investors section of the Company’s website.

About Myomo
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. It is currently the only marketed device that, sensing a patient’s own EMG signals through non-invasive sensors on the arm, can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Boston, Massachusetts, with sales and clinical professionals across the U.S. and representatives internationally. For more information, please visit www.myomo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220309005907/en/

Myomo:

ir@myomo.com

LHA Investor Relations:

Kim Sutton Golodetz

kgolodetz@lhai.com

212-838-3777

Source: Myomo, Inc.

FAQ

What conferences is Myomo participating in March 2022?

Myomo will participate in the 34th Annual ROTH Conference from March 13-15 and Oppenheimer’s 32nd Annual Healthcare Conference from March 15-16.

What is the date of Myomo's Fireside Chat at the ROTH Conference?

Myomo's Fireside Chat at the ROTH Conference is scheduled for March 14, 2022, at 2:00 p.m. PT.

When will Myomo present at the Oppenheimer Healthcare Conference?

Myomo will deliver its presentation on March 16, 2022, at 2:00 p.m. ET.

How can I access the live webcast of Myomo's presentation?

The live webcast of Myomo's presentation can be accessed via their investor section or through the link provided in their press release.

What is MyoPro by Myomo?

MyoPro is a powered upper-limb orthosis developed by Myomo, designed to assist individuals with upper-limb paralysis in regaining arm and hand functionality.